13 events about "nuevo nordisk"

25 May 2026, 15:22

The European Medicines Agency has recommended the approval of the Wegovy tablet, a weight loss medication from Novo Nordisk.

Sources

International

18 February 2026, 08:17

The European Commission has approved the 7.2 mg dose of the medication Wegovy, which can support a more pronounced weight loss.

Sources

International

Data Talks 2026 brought together 180 leaders and experts to analyze the opportunities and risks of AI agents in companies

Sources

Novo Nordisk's earnings fell by 20% following warnings about price pressures in 2026

Sources

International

24 December 2025, 07:25

Novo Nordisk's shares rose by 9.2% after the Danish company became the first to receive FDA approval for the GLP-1 pill Wegovy, intended for weight loss.

Sources

International

23 December 2025, 08:52

The U.S. Food and Drug Administration (FDA) has approved the weight loss pill Wegovy, developed by Novo Nordisk.

Sources

+4

Health

25 November 2025, 04:46

Novo Nordisk has announced that the study for semaglutide in the treatment of Alzheimer did not meet its objectives, causing a 10% drop in shares.

Sources

Economy

15 November 2025, 04:32

European stocks closed lower on Friday, affected by fears of a speculative bubble in AI and the weakness of the global economy.

Sources

Economy

9 November 2025, 06:25

Pfizer won the auction for the acquisition of Metsera, with a bid of 10 billion dollars, thus ending the competition with Novo Nordisk.

Sources

International

4 November 2025, 06:17

Pfizer has sued Novo Nordisk, accusing it of anti-competitive practices in an attempt to take over Metsera, a potential competitor in the obesity treatment market.

Sources

Health

22 October 2025, 05:51

Crisis at the peak of Novo Nordisk, at one point the most valuable European company. The president and several independent directors resign after a conflict with the majority shareholder.

Sources

International

10 September 2025, 09:28

The pharmaceutical giant Novo Nordisk announced the availability of 9,000 employees, equivalent to 11.5% of its workforce.

Sources

+2

International

Municipalities are letting licenses expire, while slot machine parlors are closing in major cities. Players are moving online

Sources

Novo Nordisk has appointed a new CEO, Maziar Mike Doustdar, and revised its financial estimates for 2023, forecasting a decline in sales.

Sources

Economy

16 October 2024, 09:14

The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.

Sources

Health

Personalized news feed, AI-powered search, and notifications in a more interactive experience.

app preview

google play badge